These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3907070)

  • 21. Fetal movement monitoring in normal and high-risk pregnancy.
    Ehrström C
    Acta Obstet Gynecol Scand Suppl; 1979; 80():1-32. PubMed ID: 283683
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ultrasonic follow-up studies of the role of biparietal and thoracic diameters, as well as placental maturity, in the diagnosis of growth retardation].
    Kovács L; Szikszai P
    Orv Hetil; 1985 Dec; 126(48):2951-2, 2955-6. PubMed ID: 3906509
    [No Abstract]   [Full Text] [Related]  

  • 23. [Human placental lactogen in the blood in fetal growth retardation].
    Bila S; Sulović V; Genbacev O
    Srp Arh Celok Lek; 1980 Apr; 108(4):317-24. PubMed ID: 7233269
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fetal intrauterine growth retardation: possibilities of antepartum diagnosis].
    Benz J
    Schweiz Rundsch Med Prax; 1987 Mar; 76(14):366-74. PubMed ID: 3296093
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
    Markestad T; Bergsjø P; Aakvaag A; Lie RT; Jacobsen G; Hoffman HJ; Bakketeig LS
    Acta Obstet Gynecol Scand Suppl; 1997; 165():50-5. PubMed ID: 9219457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Placental perfusion, endocrine parameters of pregnancy and cardiotocographic non-stress tests in cases of intrauterine retardation].
    Doszpod J; Török M; Prievara F; Csákány MG; Gáti I
    Zentralbl Gynakol; 1984; 106(21):1413-8. PubMed ID: 6516633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indications of ultrasonography in perinatal medicine (author's transl)].
    Kratochwil A
    Padiatr Padol; 1982; 17(2):341-52. PubMed ID: 7099687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of biochemical parameters for the diagnosis and therapy of chronic placental insufficiency].
    Lang N
    Gynakol Rundsch; 1987; 27 Suppl 2():108-15. PubMed ID: 3428704
    [No Abstract]   [Full Text] [Related]  

  • 29. [Urinary estriol, serum HPL and intrauterine retardation of fetal growth].
    Iarŭkov A
    Akush Ginekol (Sofiia); 1987; 26(1):20-4. PubMed ID: 3592103
    [No Abstract]   [Full Text] [Related]  

  • 30. Fetal biparietal diameter an placental grade: predictors of intrauterine growth retardation.
    Kazzi GM; Gross TL; Sokol RJ
    Obstet Gynecol; 1983 Dec; 62(6):755-9. PubMed ID: 6634003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of biochemical assays in assessing an IUGR risk-group, preselected with ultrasound fetometry.
    Laurin J; Persson PH; Fernlund P
    Eur J Obstet Gynecol Reprod Biol; 1987 Mar; 24(3):177-87. PubMed ID: 2951284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human placental lactogen in fetal hypotrophy].
    Ruseva R; Marinov B; Vlasova D
    Akush Ginekol (Sofiia); 1988; 27(2):18-21. PubMed ID: 3414896
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis of growth retardation by biochemical methods.
    Klopper A
    Clin Obstet Gynaecol; 1984 Aug; 11(2):437-55. PubMed ID: 6332704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased low-density lipoprotein susceptibility to oxidation in pregnancies and fetal growth restriction.
    Sánchez-Vera I; Bonet B; Viana M; Quintanar A; López-Salva A
    Obstet Gynecol; 2005 Aug; 106(2):345-51. PubMed ID: 16055586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between the biparietal diameter of the fetal head, human placental lactogen (HPL), thermostable alkaline phosphatase, and blood oxytocinase in risk pregnancy].
    Lukacín S; Sedlák J; Rod J; Strozová A; Jurcová E; Fialová B
    Bratisl Lek Listy; 1981 Feb; 75(2):179-84. PubMed ID: 7214183
    [No Abstract]   [Full Text] [Related]  

  • 36. [Significance of composite scoring of biochemical monitoring in fetal distress].
    Zhu FQ
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):136-9, 187. PubMed ID: 1874054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative significance of human placental lactogen in the diagnosis of retarded fetal growth.
    Daikoku NH; Tyson JE; Graf C; Scott R; Smith B; Johnson JW; King TM
    Am J Obstet Gynecol; 1979 Oct; 135(4):516-21. PubMed ID: 484651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gravidogram and fetal growth. Comparison with biochemical supervision.
    Westin B
    Acta Obstet Gynecol Scand; 1977; 56(4):273-82. PubMed ID: 602692
    [No Abstract]   [Full Text] [Related]  

  • 39. Fetal growth.
    Campbell S
    Clin Obstet Gynaecol; 1974 Apr; 1(1):41-65. PubMed ID: 4471498
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of antenatal tests of fetal welfare.
    Morrison J; Chang A; Keeping JD; Kilvert G
    Aust Fam Physician; 1982 Feb; 11(2):88-93. PubMed ID: 7073620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.